Functionally Improved Mesenchymal Stem Cells to Better Treat Myocardial Infarction

Myocardial infarction (MI) is one of the leading causes of death worldwide. Mesenchymal stem cell (MSC) transplantation is considered a promising approach and has made significant progress in preclinical studies and clinical trials for treating MI. However, hurdles including poor survival, retention...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhi, Chen, Long, Zeng, Chunyu, Wang, Wei Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286742/
https://www.ncbi.nlm.nih.gov/pubmed/30622568
http://dx.doi.org/10.1155/2018/7045245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286742/
https://www.ncbi.nlm.nih.gov/pubmed/30622568
http://dx.doi.org/10.1155/2018/7045245

Ejemplares similares